Harding K, Cutting K, Price P
Wound Healing Research Unit, Cardiff Medicentre, Cardiff, UK.
Br J Nurs. 2000 Oct;9(19 Suppl):S6, S8, S10 passim. doi: 10.12968/bjon.2000.9.Sup3.12483.
A European cost-effectiveness study has been conducted using published clinical trial data from multinational studies on chronic venous leg ulcers and pressure sores. Data relevant to UK chronic wound management practice have been extracted and are presented here. A total of 15 pressure sore studies involving 519 wounds, and 12 leg ulcer studies involving 843 ulcers were used in a pooled analysis. The study objectives included the calculation of comparative costs in pound sterling for three different treatment protocols for each wound type. The protocols have been adapted for UK clinical practice in both hospital and community settings and are based on primary dressings and nurse time costs, wound cleansing and debridement, the use of fillers, and compression as appropriate. The focus of the study has been the cost-effectiveness comparison (as measured by cost per healed wound) of two modern dressings - Granuflex(R) hydrocolloid dressing and Apligraf(R) skin replacement - and traditional gauze dressings in the treatment of venous leg ulcers and, in the case of pressure sores, comparison of Granuflex(R) Comfeel(R) hydrocolloid dressings and traditional saline gauze dressings. The choice of dressings studied was dictated by the available published literature. The construction of treatment protocols and assumptions on treatments otherwise missing from published papers has been achieved through the use of an expert panel. Results show Granuflex(R) to be 50% more cost-effective, at 422 pounds per healed wound, than Comfeel(R) (643 pounds) and 500% more so than saline gauze (2548 pounds) in the treatment of pressure sores. Granuflex(R) at 342 pounds was also more cost-effective than gauze (541 pounds) or Apligraf(R) (6741 pounds) in the treatment of venous leg ulcers. These data will provide a valuable adjunct to published clinical evidence, offering further information upon which carers can base their choice of wound dressing.
一项欧洲成本效益研究利用了关于慢性腿部静脉溃疡和压疮的跨国研究中已发表的临床试验数据。已提取与英国慢性伤口管理实践相关的数据并在此呈现。在一项汇总分析中,共使用了15项涉及519处伤口的压疮研究以及12项涉及843处溃疡的腿部溃疡研究。研究目标包括计算针对每种伤口类型的三种不同治疗方案以英镑计的比较成本。这些方案已针对英国医院和社区环境中的临床实践进行了调整,基于主要敷料和护士时间成本、伤口清洁与清创、填充剂的使用以及适当的加压。该研究的重点是两种现代敷料——Granuflex®水胶体敷料和Apligraf®皮肤替代物——与传统纱布敷料在治疗腿部静脉溃疡方面的成本效益比较(以每个愈合伤口的成本衡量),对于压疮而言,则是Granuflex® Comfeel®水胶体敷料与传统生理盐水纱布敷料的比较。所研究敷料的选择由现有已发表文献决定。通过使用专家小组实现了治疗方案的构建以及对已发表论文中未提及的其他治疗假设。结果显示,在治疗压疮方面,Granuflex®每愈合一个伤口成本为422英镑,比Comfeel®(643英镑)成本效益高50%,比生理盐水纱布(2548英镑)高500%。在治疗腿部静脉溃疡方面,Granuflex®成本为342英镑时,也比纱布(541英镑)或Apligraf®(6741英镑)更具成本效益。这些数据将为已发表的临床证据提供有价值的补充,提供更多信息,护理人员可据此选择伤口敷料。